[1] Ferlay J,Shin HR,Bray F,et al. Estimates of woldwide burden of cancer in 2008: GLOBOCAN 2008[J].Int J Cancer,2010,127(12):2893-2917.
[2] Wu YF, Liang XJ, Liu YY, et al. Antisense oligonu-cleotide targeting survivin inhibits growth by inducing apoptosis in human osteosarcoma cells MG-63[J]. Neoplasma, 2010,57(6):501-506.
[3] Liang QL, Wang BR, Li GH. DcR3 and survivin are highly expressed in colo rectal carcinoma and closely correlated to its clinicopathologic parameters[J]. J Zhejiang Univ Sci B,2009,10(9):675-682.
[4] 胡华梅, 杨晓亚, 熊 刚,等. 食管鳞状细胞癌survivin 表达与其CpG岛甲基化的研究[J]. 第三军医大学学报, 2010, 32(1):13-15.
[5] Zhao J, Tenev T, Martins LM, et al. The ubiquitin-proteasome pathway regulates survivin degradation in a cell cycle-dependent manner[J]. J Cell Sci, 2000,113(Pt 23): 4363-4371.
[6] Mita AC, Mita MM, Nawrocki ST, et al. Survivin:key regulator of mitosis and apoptosis and novel target for cancer therapeutics[J]. Clin Cancer Res, 2008,14(16): 5000-5005.
[7] 曾 剑, 周星明. Survivin 在食管癌和癌转移性淋巴结中的表达[J]. 现代实用医学, 2009, 21(9):991-992.
[8] 姜艳芳,谭 岩,赵平伟,等.c-myc基因在乳腺癌、膀胱癌和肾癌组织中的扩增研究[J].实用癌症杂志,2000,16(5):458-459.
[9] 全 晖,邓 君. 荧光定量聚合酶链反应检测 c-myc 在乳腺癌诊断中的临床应用[J]. 检验医学,2011, 26(6): 361-363. |